Development of a new TNM staging system for poorly differentiated thyroid carcinoma: a multicenter cohort study
Open Access
- 19 August 2025
- journal article
- endocrinology
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1586542
Abstract
Objective: Poorly differentiated thyroid cancer (PDTC) is a rare, heterogeneous carcinoma from follicular cells, characterized by poor differentiation, aggressive spread, and poor prognosis. Currently, there is no specific staging system for PDTC. This study aimed to develop a new TNM staging system tailored to PDTC for improved disease management.Methods: A new TNM staging system was designed and internally validated using data from the US SEER database (2004-2016) on PDTC cases. External validation was performed using data from four major institutions in China. Prognostic factors influencing cancer-specific survival (CSS) were identified through Cox regression analyses. Patients were stratified into subgroups based on adjusted hazard ratios (AHRs), weighted by these prognostic factors. The new system classified patients into five stages with distinct 5-year CSS outcomes.Results: The study analyzed 1,201 PDTC cases from SEER and 85 cases from China. Among the 876 patients in the training cohort, the new TNM staging system showed superior discrimination compared to the 8th edition of the AJCC TNM system. The 5-year CSS rates for the new stages I, II, III, IVA, and IVB were 96.3%, 88.4%, 69.4%, 43.3%, and 22.3%, respectively. The new system outperformed the 8th edition in predicting CSS, as shown by time-dependent ROC curves, C-index, and calibration plots. Both internal and external validation confirmed its predictive abilities.Conclusion: The current AJCC staging system inadequately predicts PDTC prognosis. The new TNM staging system developed in this study offers improved stratification and prognosis prediction, potentially guiding more effective clinical management for PDTC.Keywords
This publication has 24 references indexed in Scilit:
- Overview of the 2022 WHO Classification of Thyroid NeoplasmsEndocrine Pathology, 2022
- Incidence and Mortality Risk Spectrum Across Aggressive Variants of Papillary Thyroid CarcinomaJAMA Oncology, 2020
- autoRPA: A web server for constructing cancer staging models by recursive partitioning analysisComputational and Structural Biotechnology Journal, 2020
- Predictive factors of outcome in poorly differentiated thyroid carcinomasEuropean Journal of Cancer, 2018
- Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort studyThe Lancet Oncology, 2016
- Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?Thyroid®, 2015
- Poorly Differentiated Thyroid Carcinoma Presenting with Gross Extrathyroidal Extension: 1986–2009 Memorial Sloan-Kettering Cancer Center ExperienceThyroid®, 2013
- The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid GlandThyroid®, 2012
- An evidence‐based review of poorly differentiated thyroid cancerWorld Journal of Surgery, 2007
- A comparison of published head and neck stage groupings in carcinomas of the oral cavityHead & Neck, 2001